Masonic Cancer Center

A Comprehensive Cancer Center designated by the National Cancer Institute

Find a Clinical Trial

Quick Search (by title or disease)
  

Go to Advanced Search for more options.

Clinical Trials Help
Contact our Cancer Information Line nurse with your questions about open or upcoming clinical trials, second opinions, or patient referrals.
ccinfo@umn.edu • 612-624-2620 • 1-888-226-2376

  Sip Protocol

Masonic Cancer Research Center
ccinfo@umn.edu • 612-624-2620 • 1-888-226-2376

Back to Search Instructions

Protocol No. 2013CG015 Principal Investigator Greengard, Emily
Phase Phase I/II
Scope National
Secondary Protocol No. AHOD1221
Title COG AHOD1221: A Phase 1/2 Study of Brentuximab Vedotin (SGN35, IND# 117117) in Combination with Gemcitabine for Pediatric and Young Adult Patients with Relapsed or Refractory Hodgkin Lymphoma
Applicable Disease Sites Hodgkin's Lymphoma
Status Open
Participating Institutions Masonic Cancer Center
Treatment Type Treatment
Contact Jodelle Dahl Phone:612-625-2994
Email:jdahl@umphysicians.umn.edu
  • ©2013 Regents of the University of Minnesota. All rights reserved.
  • The University of Minnesota is an equal opportunity educator and employer
  • Last modified on